MENU
XGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Exagen (XGN) Earnings Date & Reports

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases... Show more

A.I. Advisor
published Earnings

XGN is expected to report earnings to fall 22.43% to -16 cents per share on November 18

Exagen XGN Stock Earnings Reports
Q3'25
Est.
$-0.16
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.01
The last earnings report on July 29 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 76.77K shares outstanding, the current market capitalization sits at 27.06M.
View a ticker or compare two or three
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XGN showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1261 Liberty Way
Phone
+1 760 560-1501
Employees
179
Web
https://www.exagen.com